NCT00972309 2022-10-12
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
5 trialsNCT00694551 2019-10-04
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT02429440 2017-08-17
UroRCC
University Hospital Tuebingen
Phase 1/2 Unknown
NCT02452307 2017-08-17
Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
University Hospital Tuebingen
Phase 1/2 Unknown
NCT00109811 2013-01-23
Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed